Neurocrine Biosciences Reports First Quarter 2016 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 164.85 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $164.85 | 52 Week High | $58.46 | |||
| Open | $164.85 | 52 Week Low | $31.25 | |||
| Day High | $164.85 | P/E | N/A | |||
| Day Low | $164.85 | EPS | $-0.69 | |||
| Volume | 1,423 | |||||
